Literature DB >> 22277138

Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Stacey E Jolly1, Mihriye Mete, Hong Wang, Jianhui Zhu, Sven O E Ebbesson, V Saroja Voruganti, Anthony G Comuzzie, Barbara V Howard, Jason G Umans.   

Abstract

It is unknown what role uric acid (UA) may play in the increasing rates of cardiovascular disease (CVD) among Alaska Eskimos. UA is associated with both hypertension (HTN) and chronic kidney disease (CKD). The authors analyzed 1078 Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) participants. Estimated glomerular filtration rate (eGFR) was calculated from serum creatinine measures using the Modification of Diet in Renal Disease equation. CKD was defined by an eGFR of <60 mL/min/1.73 m(2) . The authors adjusted for age, sex, education, diabetes, hypertension (or eGFR), obesity, lipids, and smoking status; 7% (n=75) had prevalent CKD. eGFR decreased with increasing tertiles of serum UA (P<.001). UA was independently associated with prevalent CKD (adjusted odds ratio [OR] and 95% confidence interval [CI] of 2.04 (1.62-2.56), respectively). Twenty-one percent (n=230) had prevalent HTN and UA was independently associated with prevalent HTN (adjusted OR, 1.2; 95% CI, 1.1-1.5). UA is independently associated with prevalent CKD and HTN in this population.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277138      PMCID: PMC3507473          DOI: 10.1111/j.1751-7176.2011.00574.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  50 in total

1.  Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.

Authors:  Christoph Bickel; Hans J Rupprecht; Stefan Blankenberg; Gerd Rippin; Gerd Hafner; Alexander Daunhauer; Klaus-Peter Hofmann; Jürgen Meyer
Journal:  Am J Cardiol       Date:  2002-01-01       Impact factor: 2.778

2.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 3.  SLC2A9--a fructose transporter identified as a novel uric acid transporter.

Authors:  Myphuong T Le; Mohamed Shafiu; Wei Mu; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2008-07-07       Impact factor: 5.992

4.  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Authors:  M Mazzali; J Hughes; Y G Kim; J A Jefferson; D H Kang; K L Gordon; H Y Lan; S Kivlighn; R J Johnson
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

5.  Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).

Authors:  L V Franse; M Pahor; M Di Bari; R I Shorr; J Y Wan; G W Somes; W B Applegate
Journal:  J Hypertens       Date:  2000-08       Impact factor: 4.844

6.  Hyperuricemia causes glomerular hypertrophy in the rat.

Authors:  Takahiko Nakagawa; Marilda Mazzali; Duk-Hee Kang; John Kanellis; Susumu Watanabe; Laura G Sanchez-Lozada; Bernardo Rodriguez-Iturbe; Jaime Herrera-Acosta; Richard J Johnson
Journal:  Am J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.754

7.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

8.  Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.

Authors:  J Fang; M H Alderman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

9.  Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.

Authors:  Daniel I Feig; Beth Soletsky; Richard J Johnson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

10.  Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans.

Authors:  V Saroja Voruganti; Subrata D Nath; Shelley A Cole; Farook Thameem; Jeremy B Jowett; Richard Bauer; Jean W MacCluer; John Blangero; Anthony G Comuzzie; Hanna E Abboud; Nedal H Arar
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

View more
  11 in total

1.  Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling.

Authors:  Hong Liu; Xiao-Min Zhang; Yan-Li Wang; Bi-Cheng Liu
Journal:  J Nephrol       Date:  2014-04-01       Impact factor: 3.902

2.  Value of three-dimensional speckle tracking echocardiography to assess left ventricular function in hyperuricemia patients.

Authors:  Xiaojie Zhang; Qing Lu; Zhuojun Zhang; Yongle Chen; Yanan Wang; Youngshi Wang; Zheng Li; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-05-22       Impact factor: 2.980

Review 3.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

4.  Cardiovascular Disease Among Alaska Native Peoples.

Authors:  Stacey E Jolly; Barbara V Howard; Jason G Umans
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

5.  Replication of the effect of SLC2A9 genetic variation on serum uric acid levels in American Indians.

Authors:  V Saroja Voruganti; Nora Franceschini; Karin Haack; Sandra Laston; Jean W MacCluer; Jason G Umans; Anthony G Comuzzie; Kari E North; Shelley A Cole
Journal:  Eur J Hum Genet       Date:  2013-12-04       Impact factor: 4.246

Review 6.  The role of uric acid in the pathogenesis of hypertension in the young.

Authors:  Daniel I Feig
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

7.  Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study.

Authors:  Roland F Dyck; Mariam Naqshbandi Hayward; Stewart B Harris
Journal:  BMC Nephrol       Date:  2012-07-09       Impact factor: 2.388

8.  Serum Uric Acid, Alanine Aminotransferase, Hemoglobin and Red Blood Cell Count Levels in Pseudoexfoliation Syndrome.

Authors:  Hüseyin Simavlı; Yasin Yücel Bucak; Mehmet Tosun; Mesut Erdurmuş
Journal:  J Ophthalmol       Date:  2015-05-13       Impact factor: 1.909

9.  A population-specific low-frequency variant of SLC22A12 (p.W258*) explains nearby genome-wide association signals for serum uric acid concentrations among Koreans.

Authors:  Sun-Wha Im; Jeesoo Chae; Ho-Young Son; Belong Cho; Jong-Il Kim; Jin-Ho Park
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

10.  Serum uric acid still carries controversies about its role in endothelial dysfunction.

Authors:  Mustafa Cakar; Hakan Sarlak; Sevket Balta; Murat Unlu; Seref Demirbas; Sait Demirkol
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-02-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.